Evommune, Inc. · NYSE:EVMN
Pena Luis C. sold 16,787 Evommune, Inc. shares (Form 4)
Traded Jun 1, 2026 · Filed Jun 3, 2026
On Jun 1, 2026, Pena Luis C. (Director, President & CEO) sold 16,787 Evommune, Inc. shares at US$22.74 for US$382K under a trading plan, leaving 637,896 shares. Filed Jun 3, 2026 (Form 4).
- Sold
- 16,787 shares
- Price
- US$22.74
- Value
- US$382K
- Holding after
- 637,896 shares
- Trading plan
- Yes (Made under a plan set in advance)
- Role
- Director, President & CEO
The filing in full
| Date | Security | Transaction | Shares | Price | Holding after | Ownership |
|---|---|---|---|---|---|---|
| Jun 1, 2026 | Common Stock | Sale | 16,787 | US$22.74 | 637,896 | Direct |
Source
Related
- Evommune, Inc.
- Pena Luis C.
- Evommune, Inc. shareholders
- Form 4 · Pena Luis C. · Oct 15, 2026
- Form 4 · Pena Luis C. · Jun 24, 2026
- Schedule 13G · T. Rowe Price Associates Inc · Aug 14, 2026
- Schedule 13G/A · Andera Partners · Aug 14, 2026
- Schedule 13G · Point72 Asset Management, L.P. · Jul 16, 2026
- Form 4 · Carver Kyle · Jul 10, 2026
- Form 4 · Kirsch Arthur S · Jul 8, 2026